Design, development, and technical considerations for dry powder inhaler devices

被引:4
|
作者
Dhoble, Sagar [1 ]
Kapse, Archana [1 ]
Ghegade, Vaibhav [1 ]
Chogale, Manasi [1 ]
Ghodake, Vinod [1 ]
Patravale, Vandana [1 ]
Vora, Lalitkumar K. [2 ]
机构
[1] Inst Chem Technol, Dept Pharmaceut Sci & Technol, Mumbai 400019, India
[2] Queens Univ Belfast, Sch Pharm, Belfast, North Ireland
关键词
COMPUTATIONAL FLUID-DYNAMICS; DRUG-DELIVERY; PERFORMANCE; DEPOSITION; ROUGHNESS; THERAPY; SULFATE; LACTOSE; SIZE;
D O I
10.1016/j.drudis.2024.103954
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The dry powder inhaler (DPI) stands out as a highly patient-friendly and effective pulmonary formulation, surpassing traditional and other pulmonary dosage forms in certain disease conditions. The development of DPI products, however, presents more complexities than that of other dosage forms, particularly in device design and the integration of the drug formulation. This review focuses on the capabilities of DPI devices in pulmonary drug delivery, with a special emphasis on device design and formulation development. It also discusses into the principles of deep lung particle deposition and device engineering, and provides a current overview of the market for DPI devices. Furthermore, the review highlights the use of computational fluid dynamics (CFD) in DPI product design and discusses the regulatory environment surrounding these devices.
引用
收藏
页数:12
相关论文
共 50 条
  • [1] The development of a novel dry powder inhaler
    Zhang, Xi
    Ma, Yingliang
    Zhang, Liqiang
    Zhu, Jingxu
    Jin, Fang
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2012, 431 (1-2) : 45 - 52
  • [2] Inhaler technique and patient's preference for dry powder inhaler devices
    Lavorini, Federico
    Fontana, Giovanni A.
    EXPERT OPINION ON DRUG DELIVERY, 2014, 11 (01) : 1 - 3
  • [3] In vitro dry powder inhaler formulation performance considerations
    Ziffels, Susanne
    Bemelmans, Norman L.
    Durham, Phillip G.
    Hickey, Anthony J.
    JOURNAL OF CONTROLLED RELEASE, 2015, 199 : 45 - 52
  • [4] Quality by Design in Pulmonary Drug Delivery: A Review on Dry Powder Inhaler Development, Nanotherapy Approaches, and Regulatory Considerations
    Sutar, Ashish Dilip
    Verma, Rahul Kumar
    Shukla, Rahul
    AAPS PHARMSCITECH, 2024, 25 (06):
  • [5] DESIGN AND DEVELOPMENT OF A DISPOSABLE HIGH DOSE DRY POWDER INHALER FOR AMINOGLYCOSIDES
    Hoppentocht, M.
    Hagedoorn, P.
    Frijlink, H. W.
    de Boer, A. H.
    JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY, 2014, 27 (04) : A22 - A22
  • [6] DEVELOPMENT OF SALMETEROL XINAFOATE DRY POWDER FORMULATION USING INHALER DEVICES WITH DIFFERENT RESISTANCES
    Ho, Shirlene
    Parry, Mark
    Hammond, Mark
    Forbes, Ben
    JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY, 2013, 26 (05) : A14 - A14
  • [7] Development of a High Efficiency Dry Powder Inhaler: Effects of Capsule Chamber Design and Inhaler Surface Modifications
    Srinivas R. B. Behara
    Dale R. Farkas
    Michael Hindle
    P. Worth Longest
    Pharmaceutical Research, 2014, 31 : 360 - 372
  • [8] Development of a High Efficiency Dry Powder Inhaler: Effects of Capsule Chamber Design and Inhaler Surface Modifications
    Behara, Srinivas R. B.
    Farkas, Dale R.
    Hindle, Michael
    Longest, P. Worth
    PHARMACEUTICAL RESEARCH, 2014, 31 (02) : 360 - 372
  • [9] In vitro Evaluation of Dry Powder Inhaler Devices of Corticosteroid Preparations
    Tamura, Gen
    Sakae, Hirokazu
    Fujino, Satoshi
    ALLERGOLOGY INTERNATIONAL, 2012, 61 (01) : 149 - 154
  • [10] Rational design of a dry powder inhaler: device design and optimisation
    Friebel, Christian
    Steckel, Hartwig
    Mueller, Bernd W.
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 2012, 64 (09) : 1303 - 1315